Key result
Mechanical valves linked to ~36% lower mortality vs bioprostheses in dialysis patients undergoing AVR, not MVR.
Why the study?
The optimal selection of prosthetic heart valve for dialysis-dependent patients remains controversial.
Does mechanical prosthesis improve long-term survival compared to bioprosthesis in dialysis-dependent patients undergoing aortic or mitral valve replacement?
Meta-Analysis (n=10,164)
Does mechanical prosthesis improve long-term survival compared to bioprosthesis in dialysis-dependent patients undergoing aortic or mitral valve replacement?
Answers are grounded in this paper and cite their sources.
In dialysis-dependent patients, mechanical prostheses are associated with better long-term survival for aortic valve replacement, while bioprostheses may be more appropriate for mitral valve replacement.
OBJECTIVE: The optimal selection of prosthetic heart valve for dialysis-dependent patients remains controversial. We investigated the comparative effectiveness and safety of mechanical prosthesis (MP) and bioprosthesis (BP) for these patients. METHODS: After the systematic review, we included studies that involved patients on dialysis undergoing aortic valve replacement or mitral valve replacement (MVR) and reported comparative outcomes of MP and BP. Meta-analysis was performed using random-effects model. We conducted a subgroup analysis based on the valve position and postoperative international normalized ratio (INR), which was extracted from either tables or methods of each study. A meta-regression was used to examine the effects of study-level covariates. RESULTS: We included 24 retrospective studies without randomized-controlled trials, involving 10,164 participants (MP = 6934, BP = 3230). Patients undergoing aortic valve replacement with MP exhibited a better long-term survival effectiveness (hazard ratio, 0.64; 95% confidence interval [CI], 0.47-0.86). Conversely, studies including MVR demonstrated little difference in survival (hazard ratio, 0.90; 95% CI, 0.73-1.12). A meta-regression revealed that age had little effect on long-term survival difference between MP and BP (β = -0.0135, P = .433). MP had a significantly greater bleeding risk than did BP when INR was above 2.5 (incidence rate ratio, 10.58; 95% CI, 2.02-55.41). However, when INR was below 2.5, bleeding events were comparable (incidence rate ratio, 1.73; 95% CI, 0.78-3.82). The structural valve deterioration rate was significantly lower in MP (risk ratio, 0.24; 95% CI, 0.14-0.44). CONCLUSIONS: MP is a reasonable choice for dialysis-dependent patients without additional thromboembolic risk requiring aortic valve replacement, for its better long-term survival, durability, and noninferior bleeding risk compared with BP. Conversely, BP might be an appropriate selection for patients with MVR, given its similar survival rate and lower bleeding risk. Although our meta-regression demonstrates little influence of age on long-term survival difference between MP and BP, further studies stratifying patients based on age cut-off are mandatory.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2020) conducted a meta-analysis in Dialysis-dependent patients requiring heart valve replacement (n=10,164). Mechanical prosthesis vs. Bioprosthesis was evaluated on Long-term survival (aortic valve replacement) (HR 0.64, 95% CI 0.47-0.86). Mechanical prostheses were associated with better long-term survival than bioprostheses in dialysis patients undergoing aortic valve replacement, but not mitral replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: